Vaccine Development

6
Nov

Discover how VaxSkin® can transform your vaccine development

Research HighlightExplore our latest publication in Allergy: the story behind the idea and key findings.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology. This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of research
Read more
14
Oct

POSTER – Single-cell profiling of biostabilized natural human skin identifies mast cells as an important target of injected mRNA-1273 COVID-19 vaccine

Mast CellsSingle-cell profiling of biostabilized natural human skin identifies mast cells as an important target of injected mRNA-1273 COVID-19 vaccine. Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin The field of vaccination
Read more
7
Oct

POSTER – Evaluation of vaccine potency with high-dimensional immune profiling using an innovative bio-stabilized human skin model

Vaccine DevelopmentEvaluation of Vaccine Potency with High-Dimensional Immune Profiling Using an Innovative Bio-stabilized Human Skin Model Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin Scientific Context In the rapidly evolving field of
Read more
20
Sep

WEBINAR #8 – VaxSkin – Manon Scholaert

Top-level science through the eyes of an expert.The eighth Webinar. The next episode of the Genoskin Webinar series is now scheduled on October 17, 2024 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Manon Scholaert, Scientist at Genoskin. Watch the replayIn this
Read more
10
Sep

Systems Vaccinology

Unlocking the Future of Immunization - The Rise of Systems Vaccinology in Modern Vaccine DevelopmentIn the ever-evolving landscape of immunology, the emergence of systems biology has catalyzed a transformative approach to vaccine development, known as systems vaccinology. This interdisciplinary field transcends traditional methodologies by integrating vast amounts of biological data to provide a holistic understanding of how vaccines interact with
Read more
3
Sep

VIDEO – VaxSkin Tech Talk

Discover VaxSkin’s features and its real-world applications with this video presented by our CSO at the World Vaccine Congress Europe.